Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Dec 15:8:303.
doi: 10.3389/fnagi.2016.00303. eCollection 2016.

Dysregulation of Ubiquitin-Proteasome System in Neurodegenerative Diseases

Affiliations
Review

Dysregulation of Ubiquitin-Proteasome System in Neurodegenerative Diseases

Qiuyang Zheng et al. Front Aging Neurosci. .

Abstract

The ubiquitin-proteasome system (UPS) is one of the major protein degradation pathways, where abnormal UPS function has been observed in cancer and neurological diseases. Many neurodegenerative diseases share a common pathological feature, namely intracellular ubiquitin-positive inclusions formed by aggregate-prone neurotoxic proteins. This suggests that dysfunction of the UPS in neurodegenerative diseases contributes to the accumulation of neurotoxic proteins and to instigate neurodegeneration. Here, we review recent findings describing various aspects of UPS dysregulation in neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, and Huntington's disease.

Keywords: Alzheimer’s disease; Huntington’s disease; Parkinson’s disease; deubiquitinating enzyme; proteasome; ubiquitin.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Ubiquitination and ubiquitin-proteasome system. Ubiquitination is a posttranslational modification that the ubiquitin is covalently conjugated to a Lysine residue of the substrate proteins. Ubiquitin is first attached to a Cysteine residue (the active-site) of ubiquitin activating enzyme (E1 ligase) in an ATP-dependent reaction. Subsequently, the activated ubiquitin will be transferred to a Cysteine residue of conjugating enzyme (E2 ligase). Finally, working with a specific E3 ligase, E2 ligase can transfer the (poly)ubiquitin to a Lysine residue of the substrate. There are three major classes of E3 ligases, including RING E3 ligases, HECT E3 ligases, and RBR E3 ligases. RING E3 ligases catalyze the transfer of ubiquitin directly from E2 ligases to the substrate. However, the activated ubiquitin is first transferred from E2 ligases to HECT or RBR E3 ligases and then be transferred to the substrate from the E3 ligases. Lys48-linked polyubiquitin chains usually target proteins for proteasomal degradation, whereas Lys63-linked polyubiquitination is involved in regulation of NFκB signaling. Lys27-linked polyubiquitination is important in regulating mitophagy, and Lys11-linked polyubiquitin chains are implicated in cell cycle regulation. Ubiquitination is reversed by deubiquitinating enzymes (DUBs). DUBs are crucial for determining the fate of ubiquitinated proteins through removing/editing the length/type of polyubiquitin chains. In addition, DUBs can disassemble unanchored ubiquitin chains for ubiquitin recycling.

References

    1. Abou-Sleiman P. M., Healy D. G., Quinn N., Lees A. J., Wood N. W. (2003). The role of pathogenic DJ-1 mutations in Parkinson’s disease. Ann. Neurol. 54 283–286. 10.1002/ana.10675 - DOI - PubMed
    1. Adorno M., Sikandar S., Mitra S. S., Kuo A., Nicolis Di Robilant B., Haro-Acosta V., et al. (2013). Usp16 contributes to somatic stem-cell defects in Down’s syndrome. Nature 501 380–384. 10.1038/nature12530 - DOI - PMC - PubMed
    1. Amerik A. Y., Hochstrasser M. (2004). Mechanism and function of deubiquitinating enzymes. Biochem. Biophys. Acta 1695 189–207. 10.1016/j.bbamcr.2004.10.003 - DOI - PubMed
    1. Atkin G., Paulson H. (2014). Ubiquitin pathways in neurodegenerative disease. Front. Mol. Neurosci. 7:63 10.3389/fnmol.2014.00063 - DOI - PMC - PubMed
    1. Audrain M., Fol R., Dutar P., Potier B., Billard J. M., Flament J., et al. (2016). Alzheimer’s disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression. Mol. Neurodegener. 11:5 10.1186/s13024-016-0070-y - DOI - PMC - PubMed